MedTrace Logo

Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

NCT05526443 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2025-11-21

No results posted yet for this study

Summary

To systematically collect and analyse real-world data on treatment patterns, clinical outcomes and toxicities among patients with advanced pancreatic ductal adenocarcinoma (PDAC) undergoing systematic treatment in Austria

Conditions

Interventions

DRUG

all approved chemotherapeutic agents from second line

all approved chemotherapeutic agents from second line

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Jakob Riedl, Priv.Doz. Dr. · Medical University of Graz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-13
Primary Completion
2027-03-31
Completion
2027-09-30

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05526443 on ClinicalTrials.gov